Citation: | GUO Qisheng, YE Yongsheng, WANG Yangguang, SONG Jinling, GAO Meng, DAI Seying, ZHANG Jin, FAN Yinguang. Survival analysis of HIV/AIDS in Anhui among different AIDS diagnosis and treatment guidelines, 2006-2022[J]. CHINESE JOURNAL OF DISEASE CONTROL & PREVENTION, 2024, 28(12): 1399-1405. doi: 10.16462/j.cnki.zhjbkz.2024.12.006 |
[1] |
Li Y, Zhang XW, Liao B, et al. Social support status and associated factors among people living with HIV/AIDS in Kunming city, China [J]. BMC Public Health, 2021, 21(1): 1413. DOI: 10.1186/s12889-021-11253-2.
|
[2] |
Wang CW, Chan CLW, Ho RTH. HIV/AIDS-related deaths in China, 2000-2012 [J]. AIDS Care, 2015, 27(7): 849-854. DOI: 10.1080/09540121.2015.1005568.
|
[3] |
Zhang D, Wu JJ, Zhang Y, et al. Genetic characterization of HIV-1 epidemic in Anhui Province, China [J]. Virol J, 2020, 17(1): 17. DOI: 10.1186/s12985-020-1281-y.
|
[4] |
Zhang FJ, Dou ZH, Ma Y, et al. Effect of earlier initiation of antiretroviral treatment and increased treatment coverage on HIV-related mortality in China: a national observational cohort study [J]. Lancet Infect Dis, 2011, 11(7): 516-524. DOI: 10.1016/S1473-3099(11)70097-4.
|
[5] |
World Health Organization (WHO). Guideline on when to start antiretroviral therapy and on pre-exposure prophylaxis for HIV [EB/OL]. (2015-09-01)[2024-09-26].
|
[6] |
戴色莺, 刘爱文, 沈月兰, 等. 安徽省接受抗病毒治疗HIV/AIDS死亡的影响因素[J]. 中华疾病控制杂志, 2022, 26(12): 1379-1383, 1401. DOI: 10.16462/j.cnki.zhjbkz.2022.12.003.
Dai SY, Liu AW, Shen YL, et al. Influencing factors on the death of HIV/AIDS patients receiving antiretroviral therapy in Anhui Province [J]. Chin J Dis Control Prev, 2022, 26(12): 1379-1383, 1401. DOI: 10.16462/j.cnki.zhjbkz.2022.12.003.
|
[7] |
中华医学会感染病学分会艾滋病学组制订. 艾滋病诊疗指南[J]. 中华传染病杂志, 2006, 24(2): 133-144. DOI: 10.3760/j.issn:1000-6680.2006.02.021.
AIDS Working Group of the Society of Infectious Diseases, Chinese Medical Association. AIDS diagnosis and treatment guide [J]. Chin J Infect Dis, 2006, 24(2): 133-144. DOI: 10.3760/j.issn:1000-6680.2006.02.021.
|
[8] |
Ke SS, Fang Q, Lan JG, et al. Survival times of HIV/AIDS in different AIDS diagnostic and treatment guidelines from 2006 to 2020 in Liuzhou, China [J]. BMC Public Health, 2023, 23(1): 1745. DOI: 10.1186/s12889-023-15662-3.
|
[9] |
孙建军, 卢洪洲. 《艾滋病诊疗指南第三版(2015版)》更新解读[J]. 浙江大学学报(医学版), 2015, 44(6): 597-602. DOI: 10.3785/j.issn.1008-9292.2015.11.01.
Sun JJ, Lu HZ. Highlights of the third edition of Chinese guidelines for AIDS diagnosis and treatment (2015) [J]. J Zhejiang Univ Med Sci, 2015, 44(6): 597-602. DOI: 10.3785/j.issn.1008-9292.2015.11.01.
|
[10] |
中华医学会感染病学分会艾滋病丙型肝炎学组, 中国疾病预防控制中心. 中国艾滋病诊疗指南(2018年版) [J]. 中华内科杂志, 2018, 57(12): 867-884. DOI: 10.3760/cma.j.issn.0578-1426.2018.12.002.
AIDS and Hepatitis C Professional Group Society of Infectious Diseases, Chinese Center for Disease Control and Prevention. Chinese guidelines for diagnosis and treatment of HIV/AIDS (2018) [J]. Chin J Intern Med, 2018, 57(12): 867-884. DOI: 10.3760/cma.j.issn.0578-1426.2018.12.002.
|
[11] |
中华医学会感染病学分会艾滋病丙型肝炎学组, 中国疾病预防控制中心. 中国艾滋病诊疗指南(2021年版) [J]. 中华内科杂志, 2021, 60(12): 1106-1128. DOI: 10.3760/cma.j.cn112138-20211006-00676.
AIDS and Hepatitis C Professional Group Society of Infectious Diseases, Chinese Center for Disease Control and Prevention. Chinese guidelines for diagnosis and treatment of HIV/AIDS (2021 edition) [J]. Chin J Intern Med, 2021, 60(12): 1106-1128. DOI: 10.3760/cma.j.cn112138-20211006-00676.
|
[12] |
Zhao Y, Wei L, Dou ZH, et al. Changing mortality and patterns of death causes in HIV infected patients - China, 2013-2022 [J]. China CDC Wkly, 2023, 5(48): 1073-1078. DOI: 10.46234/ccdcw2023.201.
|
[13] |
金怡晨, 秦倩倩, 蔡畅, 等. 中国2011―2020年新报告HIV/AIDS短期内死亡特征及风险因素[J]. 中华疾病控制杂志, 2023, 27(6): 673-677. DOI: 10.16462/j.cnki.zhjbkz.2023.06.010.
Jin YC, Qin QQ, Cai C, et al. Characteristics and risk factors of early death among newly diagnosed HIV/AIDS in China, 2011-2020 [J]. Chin J Dis Control Prev, 2023, 27(6): 673-677. DOI: 10.16462/j.cnki.zhjbkz.2023.06.010.
|
[14] |
Mao NL, Pan HF, Lu MM, et al. AIDS awareness and condom use among patients in a high-HIV-prevalence area in rural northern Anhui, China [J]. J Investig Med, 2010, 58(6): 801-803. DOI: 10.231/JIM.0b013e3181e80188.
|
[15] |
范引光, 朱志伟, 马炜祥, 等. 安徽省阜阳市HIV/HCV共感染者抗病毒治疗服药依从性及影响因素分析[J]. 中华疾病控制杂志, 2017, 21(12): 1204-1208. DOI: 10.16462/j.cnki.zhjbkz.2017.12.005.
Fan YG, Zhu ZW, Ma WX, et al. Study on influencial factors of adherence to anti-retroviral treatment among people who co-infected with HIV/HCV in Fuyang City, Anhui Province [J]. Chin J Dis Control Prev, 2017, 21(12): 1204-1208. DOI: 10.16462/j.cnki.zhjbkz.2017.12.005.
|
[16] |
Zheng ZG, Nehl EJ, Zhou CX, et al. Insufficient tuberculosis treatment leads to earlier and higher mortality in individuals co-infected with HIV in Southern China: a cohort study [J]. BMC Infect Dis, 2020, 20(1): 873. DOI: 10.1186/s12879-020-05527-0.
|
[17] |
Hunt PW, Lee SA, Siedner MJ. Immunologic biomarkers, morbidity, and mortality in treated HIV infection [J]. J Infect Dis, 2016, 214(Suppl 2): S44-S50. DOI: 10.1093/infdis/jiw275.
|
[18] |
Kim YC, Ahn JY, Kim HY, et al. Survival trend of HIV/AIDS patients starting antiretroviral therapy in South Korea between 2001 and 2015 [J]. Yonsei Med J, 2020, 61(8): 705-711. DOI: 10.3349/ymj.2020.61.8.705.
|
[19] |
周超, 陈宗良, 吴国辉, 等. 2014―2018年重庆市中老年艾滋病抗病毒治疗患者生存状况分析[J]. 预防医学情报杂志, 2019, 35(12): 1379-1383.
Zhou C, Chen ZL, Wu GH, et al. Analysis of the survival conditions and associated factors of middle-aged and older hiv/aids patients receiving antiretroviral therapy in Chongqing city from 2014 to 2018 [J]. J Prev Med Inf, 2019, 35(12): 1379-1383.
|